Interferome v2. 0: an updated database of annotated interferon-regulated genes

I Rusinova, S Forster, S Yu, A Kannan… - Nucleic acids …, 2012 - academic.oup.com
I Rusinova, S Forster, S Yu, A Kannan, M Masse, H Cumming, R Chapman, PJ Hertzog
Nucleic acids research, 2012academic.oup.com
Abstract Interferome v2. 0 (http://interferome. its. monash. edu. au/interferome/) is an update
of an earlier version of the Interferome DB published in the 2009 NAR database edition.
Vastly improved computational infrastructure now enables more complex and faster queries,
and supports more data sets from types I, II and III interferon (IFN)-treated cells, mice or
humans. Quantitative, MIAME compliant data are collected, subjected to thorough,
standardized, quantitative and statistical analyses and then significant changes in gene …
Abstract
Interferome v2.0 (http://interferome.its.monash.edu.au/interferome/) is an update of an earlier version of the Interferome DB published in the 2009 NAR database edition. Vastly improved computational infrastructure now enables more complex and faster queries, and supports more data sets from types I, II and III interferon (IFN)-treated cells, mice or humans. Quantitative, MIAME compliant data are collected, subjected to thorough, standardized, quantitative and statistical analyses and then significant changes in gene expression are uploaded. Comprehensive manual collection of metadata in v2.0 allows flexible, detailed search capacity including the parameters: range of -fold change, IFN type, concentration and time, and cell/tissue type. There is no limit to the number of genes that can be used to search the database in a single query. Secondary analysis such as gene ontology, regulatory factors, chromosomal location or tissue expression plots of IFN-regulated genes (IRGs) can be performed in Interferome v2.0, or data can be downloaded in convenient text formats compatible with common secondary analysis programs. Given the importance of IFN to innate immune responses in infectious, inflammatory diseases and cancer, this upgrade of the Interferome to version 2.0 will facilitate the identification of gene signatures of importance in the pathogenesis of these diseases.
Oxford University Press